Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Olive compound could spark brown fat to fight obesity

NCT ID NCT06484543

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether maslinic acid, a natural compound found in olive skins, can improve metabolic health by activating brown fat—a type of fat that burns calories. Fifty adults with pre-metabolic syndrome or mild obesity will take maslinic acid or a placebo for 12 weeks. Researchers will measure changes in blood sugar, body fat, energy use, and other markers of metabolic health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Maslinic acid (a natural compound found in olive skins and other plants)
What this could lead to
If it works, this could point toward a simple, natural supplement to help manage obesity and related metabolic problems like insulin resistance.
What could go wrong
This is an early-stage trial with only 50 participants, all of Chinese ethnicity, so results may not apply to everyone. The compound is a nutraceutical, not a drug, so effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or Female * Chinese ethnicity * Age between 21 to 60 years• Able to give informed consent * Body mass index (BMI) between 23 to 32 kg/m2 * Thyroid function test must be within the normal ranges * Willing to avail yourself for the whole study and follow study procedures * EITHER deemed to have pre-metabolic syndrome when waist circumference is \> 90 cm in men or \> 80 cm in women, with none or up to one of the following condition: 1. Triglyceride level \>/= 1.7 mmol/L 2. HDL cholesterol \</= 1.0 mmol/L in men, and \</= 1.3 mmol/L in women 3. Blood pressure \>/= 130/85 mmHg 4. Fasting blood glucose \>/= 6.1 mmol/L * OR deemed to have metabolic syndrome when three or more of the following conditions are present: 1. Waist circumference \> 90 cm in men and \> 80 cm in women 2. Triglyceride level \>/= 1.7 mmol/L 3. HDL cholesterol\</= 1.0 mmol/L in men, and \</= 1.3 mmol/L in women 4. Blood pressure \>/= 130/85 mmHg 5. Fasting blood glucose \>/= 6.1 mmol/L Exclusion Criteria: * Are pregnant or contemplating pregnancy (for female subjects) * Partake in sports at the competitive and/ or endurance levels * Have known glucose-6-phosphate dehydrogenase (G6PD) deficiency * Have major chronic disease such as heart disease or cancer * Take insulin or drugs known to affect glucose metabolism * Intentionally restrict food intake * Have major medical or surgical event requiring hospitalization within the preceding 3 months * Have taken antibiotics for 3 months before the study period * Are a smoker * Are an overnight shift worker * Have any known food allergy (eg. anaphylaxis to peanuts) or skin allergy (eg. rashes due to alcohol, etc) * Having active Tuberculosis (TB) or currently receiving treatment for TB * Have any known Chronic Infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV) * Are a member of the research team or their immediate family members. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted * Enrolled in a concurrent research study judged not to be scientifically or medically compatible with this study * Have poor veins impeding venous access * Have any history of severe vasovagal syncope (blackouts or near faints) following blood draws * History of claustrophobia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brown adipose tissue are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Singapore Institute of Clinical Sciences

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.